These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7131270)

  • 21. Absorption kinetics of rectally and orally administered ibuprofen.
    Eller MG; Wright C; Della-Coletta AA
    Biopharm Drug Dispos; 1989; 10(3):269-78. PubMed ID: 2720131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity and pharmacokinetics of a new oral dosage form of soluble ibuprofen.
    Ceppi Monti N; Gazzaniga A; Gianesello V; Stroppolo F; Lodola E
    Arzneimittelforschung; 1992 Apr; 42(4):556-9. PubMed ID: 1642682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methylphenidate bioavailability from two extended-release formulations.
    González MA; Pentikis HS; Anderl N; Benedict MF; DeCory HH; Dirksen SJ; Hatch SJ
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):175-84. PubMed ID: 11996212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules.
    Walter K; Weiss G; Laicher A; Stanislaus F
    Arzneimittelforschung; 1995 Aug; 45(8):886-90. PubMed ID: 7575754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relation of product formulation to absorption of oral theophylline.
    Weinberger M; Hendeles L; Bighley L
    N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relative bioavailability of a commercial propranolol hydrochloride tablet in man.
    Roscoe R; Cooper J; Wilson TW; Joshi NN; Midha KK
    Biopharm Drug Dispos; 1982; 3(2):105-14. PubMed ID: 7104460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of digoxin in a new soluble pharmaceutical formulation in capsules.
    Ghirardi P; Catenazzo G; Mantero O; Merotti GC; Marzo A
    J Pharm Sci; 1977 Feb; 66(2):267-9. PubMed ID: 839426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soft, chewable gelatin-based pharmaceutical oral formulations: a technical approach.
    Dille MJ; Hattrem MN; Draget KI
    Pharm Dev Technol; 2018 Jun; 23(5):504-511. PubMed ID: 28532266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A completely absorbed oral preparation of digoxin.
    Johnson BF; Bye C; Jones G; Sabey GA
    Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The bioavailability of flufenamic acid from aluminum flufenamate tablet and flufenamic acid capsule, and the influence of food and aluminum hydroxide gel.
    Kaniwa N; Ogata H; Aoyagi N; Ejima A
    J Pharmacobiodyn; 1982 Mar; 5(3):187-92. PubMed ID: 7097486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple-dose pharmacokinetics and bioequivalence of L-carnitine 330-mg tablet versus 1-g chewable tablet versus enteral solution in healthy adult male volunteers.
    Sahajwalla CG; Helton ED; Purich ED; Hoppel CL; Cabana BE
    J Pharm Sci; 1995 May; 84(5):627-33. PubMed ID: 7658356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique.
    Li DX; Oh YK; Lim SJ; Kim JO; Yang HJ; Sung JH; Yong CS; Choi HG
    Int J Pharm; 2008 May; 355(1-2):277-84. PubMed ID: 18243606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diclofenac potassium 12.5 mg liquid capsules: earlier and higher exposure to diclofenac. A fasted, single-dose, comparative, bioavailability study versus diclofenac potassium 12.5 mg tablets.
    Kienzler JL; Gold M
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):438-44. PubMed ID: 22677305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The assessment of the intrasubject variability in digoxin absorption in man from two oral dosage forms.
    Yacobi A; Stoll RG; Chao GC; Schwartz RA; Weidler DJ; Ayers JW; Sakmar E; Hallmark M; Wagner JG
    J Clin Pharmacol; 1981 Jul; 21(7):301-10. PubMed ID: 7263929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution.
    Edwards G; Dingsdale A; Helsby N; Orme ML; Breckenridge AM
    Eur J Clin Pharmacol; 1988; 35(6):681-4. PubMed ID: 3234475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chlorothiazide absorption from solution and tablet dosage forms in dogs.
    Ebling WF; Murro AF; Voelker FJ; Resetarits DE; Bates TR
    J Pharm Sci; 1981 Feb; 70(2):224-6. PubMed ID: 7205233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioavailability and pharmacokinetics of a new, slow-release potassium chloride capsule.
    Arnold J; Jacob JT; Riley B
    J Pharm Sci; 1980 Dec; 69(12):1416-8. PubMed ID: 7463329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.